N07.4 Hereditary nephropathy, not elsewhere classified with diffuse endocapillary proliferative glomerulonephritis

Name of the Condition

• Hereditary Nephropathy, Not Elsewhere Classified with Diffuse Endocapillary Proliferative Glomerulonephritis
• ICD-10 Code: N07.4

Summary

Hereditary nephropathy, not elsewhere classified with diffuse endocapillary proliferative glomerulonephritis, is a genetic kidney disorder characterized by inherited diffuse proliferative changes in the glomeruli, the kidney's filtering units. This condition involves widespread endocapillary proliferation, which can impair filtration and lead to progressive renal dysfunction. It is distinct from other hereditary nephropathies due to its specific glomerular pathology and is managed by addressing underlying mechanisms and complications.

Causes

This condition is caused by genetic mutations that affect kidney structure or function, often inherited in an autosomal dominant or recessive pattern. The mutations disrupt normal glomerular development or filtration, leading to diffuse endocapillary proliferation. While some genetic defects are identifiable, others remain undefined, and the diagnosis is made when hereditary kidney disease does not align with more specific subtypes.

Risk Factors

• Family history of kidney disease: A genetic predisposition increases risk.
• Inherited genetic mutations: Specific gene variants associated with glomerular abnormalities.
• Consanguinity: Higher likelihood of recessive disorders in closely related families.

Symptoms

• Hematuria (blood in urine), which may be microscopic or visible.
• Proteinuria (excess protein in urine), potentially causing foamy urine.
• Reduced kidney function, which may be asymptomatic initially but can progress to edema, hypertension, or renal insufficiency.

Diagnosis

Diagnosis involves a combination of clinical evaluation, family history, and laboratory tests. Urinalysis may reveal hematuria or proteinuria. Imaging studies assess kidney structure, while renal biopsy confirms diffuse endocapillary proliferative glomerulonephritis. Genetic testing may identify underlying mutations, though results can be inconclusive in some cases. Exclusion of other hereditary or acquired kidney diseases is essential.

Treatment Options

Treatment focuses on slowing disease progression and managing complications. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may reduce proteinuria and protect kidney function. Immunosuppressive therapies are considered in select cases, though evidence is limited. Blood pressure control and dietary modifications (e.g., low-sodium, protein-restricted diets) are standard. Renal replacement therapy may be necessary in advanced stages.

Prognosis and Follow-Up

Prognosis varies based on disease severity and response to treatment. Early intervention can delay progression, but some patients develop chronic kidney disease or end-stage renal disease. Regular monitoring of kidney function, blood pressure, and urine protein levels is critical. Follow-up care includes nephrology consultations and adjustments to therapy as needed.

Complications

• Progressive kidney failure, potentially requiring dialysis or transplantation.
• Hypertension, which can worsen renal damage.
• Edema due to protein loss or fluid retention.
• Increased risk of infections or cardiovascular events.

Lifestyle & Prevention

• Maintain a balanced diet low in sodium and protein to reduce kidney strain.
• Control blood pressure through medication and lifestyle changes.
• Avoid nephrotoxic substances (e.g., certain NSAIDs, contrast dyes).
• Stay hydrated and manage comorbidities like diabetes or obesity.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, foamy urine, unexplained swelling, or changes in urination frequency. Prompt evaluation is necessary for symptoms of kidney failure, such as fatigue, nausea, or shortness of breath. Genetic counseling is recommended for families with a history of hereditary kidney disease.

Tips for Medical Coders

Document the presence of diffuse endocapillary proliferative glomerulonephritis and confirm the hereditary nature of the nephropathy. Ensure clinical correlation with biopsy findings or genetic testing, if available. Code N07.4 is specific to this combination; avoid using it for other glomerular or hereditary nephropathies. Verify that no more specific code applies before assigning N07.4.